AIFM1 Gene Deafness X-Linked Type 5 Genetic Test sale cost 4400 AED
WHRN Gene Deafness Autosomal Recessive Type 31 Genetic Test sale cost 4400 AED WHRN Gene Deafness Autosomal Recessive Type 31 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
FLNA Gene Otopaladigital Syndrome Type 1 Genetic Test sale cost 4400 AED FLNA Gene Otopaladigital Syndrome Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

AIFM1 Gene Deafness X-Linked Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AIFM1 Gene Deafness X-Linked Type 5 Genetic Test is a specialized diagnostic tool designed to identify mutations in the AIFM1 gene, which are linked to a rare form of hereditary hearing loss known as Deafness X-Linked Type 5. This condition is characterized by progressive sensorineural hearing impairment that predominantly affects males, due to its X-linked mode of inheritance. The test is crucial for families with a history of this condition, as it can provide definitive diagnosis, inform about the risk of transmission to future generations, and guide decisions on management and treatment.

Conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test involves analyzing the patient’s DNA sample, typically obtained through a blood draw or a cheek swab, to detect any pathogenic variants in the AIFM1 gene. The process is comprehensive, employing advanced genetic sequencing technologies to ensure high accuracy and reliability of results.

The cost of the AIFM1 Gene Deafness X-Linked Type 5 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the intricate nature of the genetic analysis and the specialized expertise required to interpret the results. For individuals and families facing the possibility of X-linked deafness, this test represents a critical step towards understanding their genetic status and making informed health and lifestyle decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AIFM1 Gene Deafness X-linked type 5 Genetic Test

Test Name: AIFM1 Gene Deafness X-linked type 5 Genetic Test

Components: Blood Sample

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A14

Test Details

AIFM1 gene deafness, X-linked type 5 NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to identify mutations in the AIFM1 gene associated with X-linked deafness type 5. X-linked deafness type 5 is a rare genetic disorder characterized by progressive hearing loss that predominantly affects males. Mutations in the AIFM1 gene, located on the X chromosome, are responsible for this condition.

NGS technology allows for the simultaneous sequencing of multiple genes, including the AIFM1 gene, in a single test. This enables the identification of specific mutations or variants that may be responsible for the individual’s hearing loss. The AIFM1 gene provides instructions for producing a protein called apoptosis-inducing factor, mitochondria-associated 1 (AIFM1). This protein plays a crucial role in the maintenance and function of mitochondria, which are responsible for producing energy in cells.

Mutations in the AIFM1 gene can disrupt the normal function of mitochondria, leading to the degeneration of sensory cells in the inner ear and resulting in hearing loss. The NGS genetic test for AIFM1 gene deafness, X-linked type 5 involves obtaining a DNA sample, typically through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variants in the AIFM1 gene.

The test results can help confirm a diagnosis of X-linked deafness type 5 and provide valuable information for genetic counseling and family planning. It can also assist in the development of personalized treatment plans and management strategies for individuals with this condition.

Test Name AIFM1 Gene Deafness X-linked type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A14
Test Details

AIFM1 gene deafness, X-linked type 5 NGS genetic test is a diagnostic test that uses Next-Generation Sequencing (NGS) technology to identify mutations in the AIFM1 gene associated with X-linked deafness type 5.

X-linked deafness type 5 is a rare genetic disorder characterized by progressive hearing loss that predominantly affects males. Mutations in the AIFM1 gene, located on the X chromosome, are responsible for this condition.

NGS technology allows for the simultaneous sequencing of multiple genes, including the AIFM1 gene, in a single test. This enables the identification of specific mutations or variants that may be responsible for the individual’s hearing loss.

The AIFM1 gene provides instructions for producing a protein called apoptosis-inducing factor, mitochondria-associated 1 (AIFM1). This protein plays a crucial role in the maintenance and function of mitochondria, which are responsible for producing energy in cells. Mutations in the AIFM1 gene can disrupt the normal function of mitochondria, leading to the degeneration of sensory cells in the inner ear and resulting in hearing loss.

The NGS genetic test for AIFM1 gene deafness, X-linked type 5 involves obtaining a DNA sample, typically through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variants in the AIFM1 gene.

The test results can help confirm a diagnosis of X-linked deafness type 5 and provide valuable information for genetic counseling and family planning. It can also assist in the development of personalized treatment plans and management strategies for individuals with this condition.

SKU: TEST-2750 Category:

Related products